BioSpace News Archive

Biotech Bay

Unchained Labs Gives Lunatic a Boost, Nails High-End Biologic Quant!

Lunatic’s new IgG Quant app hits the upper analysis range needed to measure these protein drugs, and does it with only 2 µL of sample straight up - no dilution needed.

January 8, 2018
·
1 min read
Business

U.S. ARMY Fully Funds Spider Silk Development Contract With Kraig Biocraft Laboratories

The Company is currently utilizing multiple approaches to create these transgenics, with performance that surpasses the original Dragon SilkTM that was produced for the baseline contract.

January 8, 2018
·
2 min read
BioCapital

Emergent BioSolutions Announces Preliminary 2017 Financial Results and Provides 2018 Financial Outlook

For the full year 2017, the company anticipates total revenue of $555 to $560 million, the midpoint of which represents a $69 million or 14% increase from 2016.

January 8, 2018
·
11 min read
Business

BeiGene and Mirati Therapeutics Announce Exclusive License Agreement for Sitravatinib in the Asia Pacific Region

Mirati will retain exclusive rights for the development, manufacturing and commercialization of sitravatinib for the rest of world.

January 8, 2018
·
7 min read
Policy

Enable Injections Achieves ISO 13485:2016 Certification to Meet Mounting Demand for Drug-Delivery Device Combination Products

The new certification verifies that across the company’s operations and manufacturing, Enable Injections’ quality system and processes meet the rigorous regulatory requirements and comprehensive reviews of ISO 13485:2016 certification for medical devices and related services

January 8, 2018
·
2 min read
Policy

Acura Pharmaceuticals Announces Successful Results From Study AP-LTX-301

Current FDA approved abuse deterrent opioid formulations do not address abuse by swallowing excess numbers of tablets.

January 8, 2018
·
7 min read
Pharm Country

RenovaCare Comments on Recent Market Activity

RenovaCare today announced that on January 3rd, 2018, OTC Markets Group Inc. (“OTC Markets”) informed the Company that OTC Markets had become aware of promotional activities concerning the Company.

January 8, 2018
·
15 min read
Drug Development

Saniona Reports Top Line Results From the Tesomet Phase IIa Interim Study in Prader-Willi Syndrome

The small number of patients in the study (n=9) and the failure of one placebo and four treated patients to complete the study preempts statistical evaluation.

January 8, 2018
·
5 min read
Business

World Renowned Immunologist, Professor Eric Vivier, Joins Innate Pharma as Chief Scientific Officer

Eric Vivier is currently Professor of Immunology at Aix-Marseille University and the Marseille Public Hospitals.

January 8, 2018
·
5 min read
Business

Targovax Announces the Appointment of Michael Bogenstaetter as Chief Business Officer

Michael joins Targovax following 25 years’ experience in biotech and big pharma.

January 8, 2018
·
3 min read